1. [PP.19.01] PREVALENCE AND RISK FACTORS RELATED TO DEVELOPMENT OF ARTERIAL HYPERTENSION IN CIRRHOTIC PATIENTS UNDERGOING LIVER TRANSPLANTATION. (September 2016) Authors: Di Stefano, C.; Vanni, E.; Mirabella, S.; Jouness, R. Ibrahim Kamal; Nada, E.; Boano, V.; Mosso, E.; Milazzo, V.; Vallelonga, F.; Sobrero, G.; Salizzoni, M.; Veglio, F.; Milan, A. Journal: Journal of hypertension Issue: Volume 34:(2016) Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical patterns of hepatocellular carcinoma (HCC) in non alcoholic fatty liver disease (NAFLD): a multicenter case-control study. (15th February 2015) Authors: Piscaglia, F.; Baroni, G. Svegliati; Barchetti, A.; Pecorelli, A.; Marinelli, S.; Tiribelli, C.; Bellentani, S.; Bolondi, L.; Zoli, M.; Malagotti, D.; Brandi, G.; Bugianesi, E.; Vanni, E.; Mezzabotta, L.; Cabibbo, G.; Petta, S.; Fracanzani, A.; Fargion, S.; Marra, F.; Fani, B. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Editorial: utility and pitfalls of Fatty Liver Index in epidemiologic studies for the diagnosis of NAFLD. Issue 4 (February 2015) Authors: Vanni, E.; Bugianesi, E. Journal: Alimentary pharmacology & therapeutics Issue: Volume 41:Issue 4(2015) Page Start: 406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Epidemiological and clinical profile of 302 patients with primary biliary cholangitis in Piedmont and Liguria. (March 2021) Authors: De Benedittis, C.; Labanca, S.; Picciotto, A.; Morgando, A.; Vanni, E.; Azzolina, D.; Cittone, M.G.; Pirisi, M.; Rigamonti, C. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Insulin resistance and liver damage are associated with early signs of left ventricular systolic dysfunction in non-diabetic, non-dyslipidemic, normotensive patients with Nonalcoholic fatty Liver Disease. (15th February 2015) Authors: Vanni, E.; Mezzabotta, L.; Faletti, R.; Morello, M.; Marengo, A.; Battisti, G.; Frea, S.; Cannillo, M.; Rosso, C.; Mosso, E.; Bergamasco, L.; Rizzetto, M.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Is stiffness reliable for the detection of liver fibrosis in HCV patients treated with direct acting antiviral drugs (DAAs)? A prospective cohort study. Issue 1 (February 2018) Authors: Gaia, S.; Vanni, E.; Campion, D.; Rolle, E.; Stradella, D.; Valdivia, P. Cortegoso; Evangelista, A.; Ciancio, A.; Smedile, A.; Trapani, R.; Saracco, G.M. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liver damage can be associated with deregulation of the de novo lipogenesis pathway in subjects with Non Alcoholic Fatty Liver Disease. (15th February 2015) Authors: Rosso, C.; Saponaro, C.; Mezzabotta, L.; Vanni, E.; Gambino, R.; Saba, F.; Jouness, R. Ibrahim Kamal; Gaggini, M.; Buzzigoli, E.; Caviglia, G.P.; Abate, M.L.; Salomone, F.; Smedile, A.; Rizzetto, M.; Cassader, M.; Gastaldelli, A.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study. (March 2023) Authors: Terracciani, F.; De Vincentis, A.; D'Amato, D.; Invernizzi, P.; Morgando, A.; Vanni, E.; Viganò, M.; Alvaro, D.; Venere, R.; Lleo, A.; Colapietro, F.; Degasperi, E.; Viganò, R.; Giannini, E.G.; Labanca, S.; Feletti, V.; Mussetto, A.; Cozzolongo, R.; Losito, F.; Pompili, M. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Metabolic Syndrome after liver transplantation: have risk factors changed over time?. (15th February 2015) Authors: Vanni, E.; Jouness, R. Ibrahim Kamal; Mirabella, S.; Marengo, A.; Milan, A.; Rosso, C.; Boano, V.; Mosso, E.; Di Stefano, C.; Nada, E.; Rizzetto, M.; Salizzoni, M.; Romagnoli, R.; Bugianesi, E. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.14.7: The Role of Anti-IFI16 Antibodies in the Management of Inflammatory Bowel Diseases (IBD). (15th March 2017) Authors: Astegiano, M.; Vanni, E.; Finocchiaro, F.; Vernero, M.; Ribaldone, D.; Reggiani, S.; Caviglia, G.; De Andrea, M.; Caneparo, V.; Landolfo, S.; Gariglio, M.; Smedile, A.; Pellicano, R. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗